{
    "eid": "2-s2.0-85123529277",
    "title": "Incidence of Pneumocystis carinii pneumonia in treatment-na\u00efve HIV-infected adult patients receiving primary Pneumocystis carinii pneumonia chemoprophylaxis with 48-week antiretroviral initiation",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Acquired immune deficiency syndrome",
        "Highly active antiretroviral therapy",
        "Primary Pneumocystis carinii pneumonia"
    ],
    "authors": [
        "Piroon Khamlee",
        "Peerawong Werarak",
        "Chankit Puttilerpong"
    ],
    "citedby-count": 0,
    "ref-count": 29,
    "ref-list": [
        "The evolving epidemiology of HIV/AIDS",
        "CD 4+T-cell depletion in HIV infection: Mechanisms of immunological failure",
        "Disease progression among untreated HIV-infected patients in South Ethiopia: Implications for patient care",
        "Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and Mycobacterium avium complex incidence rates over the 30 years of the HIV epidemic: A systematic review",
        "AIDS-defining opportunistic illnesses in US patients, 1994-2007: A cohort study",
        "Current epidemiology of pneumocystis pneumonia",
        "Causes of early mortality in HIV-infected TB suspects in an East African referral hospital",
        "Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: Not all AIDS-defining conditions are created equal",
        "Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: Results from the Treat Asia HIV observational database",
        "Prescription of Pneumocystis jirovecii pneumonia prophylaxis in HIV-infected patients",
        "Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand",
        "Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy",
        "Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting",
        "Is it safe to discontinue primary Pneumocystis jirovecii pneumonia prophylaxis in patients with virologically suppressed HIV Infection and a CD4 cell count <200 cells/\u00b5L?",
        "Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: A review",
        "Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia",
        "Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy",
        "Recent advances in the diagnosis and management of Pneumocystis pneumonia",
        "Impact of the national access to antiretroviral program on the incidence of opportunistic infections in Thailand",
        "Cotrimoxazole prophylaxis and antiretroviral therapy: An observational cohort study in China",
        "Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: Using simulation modeling to inform clinical guidelines",
        "Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy",
        "AIDS across Europe, 1994-98: The EuroSIDA study",
        "CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection",
        "Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents",
        "A systematic review of Stevens-Johnson Syndrome and/or toxic epidermal necrolysis over a period of 20 years in Thailand"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Pharmacy Siriraj Hospital",
        "Division of Infectious Disease and Immune Deficiency Syndrome Siriraj Hospital",
        "Chulalongkorn University"
    ]
}